Two Distinct Regions in the 3′ Untranslated Region of Tumor Necrosis Factor Alpha mRNA Form Complexes with Macrophage Proteins

REFERENCES

• Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York.
   Google Scholar
• Beutler, B. 1990. Regulation of cachectin biosynthesis occurs at multiple levels. Prog. Clin. Biol. Res. 349: 229–420.
   PubMedGoogle Scholar
• Beutler, B., and T. Brown. 1991. A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines. J. Clin. Invest. 87: 1336–1344.
   PubMed Web of Science ®Google Scholar
• Beutler, B., and A. Cerami. 1994. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu. Rev. Biochem. 57: 505–518.
   Google Scholar
• Bickel, M., Y. Iwai, D. H. Pluznik, and R. B. Cohen. 1992. Binding of sequence-specific proteins to the adenosine- plus uridine-rich sequences of the murine granulocyte/macrophage colony-stimulating factor mRNA. Proc. Natl. Acad. Sci. USA 89: 10001–10005.
   PubMedGoogle Scholar
• Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1991. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11: 3288–3295.
   PubMed Web of Science ®Google Scholar
• Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1992. AU RNA-binding factors differ in their binding specificities and affinities. J. Biol. Chem. 267: 6302–6309.
   PubMed Web of Science ®Google Scholar
• Brewer, G. 1991. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11: 2460–2466.
   PubMed Web of Science ®Google Scholar
• Brewer, G., and J. Ross. 1989. Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol. Cell. Biol. 9: 1996–2006.
   PubMed Web of Science ®Google Scholar
• Camussi, G., E. Albano, C. Tetta, and F. Bussolino. 1991. The molecular action of tumor necrosis factor-alpha. Eur. J. Biochem. 202: 3–14.
   PubMedGoogle Scholar
• Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83: 1670–1674.
   PubMed Web of Science ®Google Scholar
• Cox, G., L. Gandino, E. Blasi, D. Radzioch, B. J. Mathieson, and L. Varesio. 1989. Heterogeneity of haematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J. Natl. Cancer Inst. 81: 1492–1496.
   PubMedGoogle Scholar
• Dignam, J. D. 1990. Preparation of extracts from higher eucaryotes. Methods Enzymol. 182: 194–203.
   PubMed Web of Science ®Google Scholar
• Donis-Keller, H., A. M. Maxam, and W. Gilbert. 1977. Mapping adenines, guanines, and pyrimidines in RNA. Nucleic Acids Res. 4: 2527–2538.
   PubMed Web of Science ®Google Scholar
• Ehreman, K., L. Long, B. J. Wagner, and G. Brewer. 1994. Characterization of cDNA encoding the murine A+U-rich RNA-binding protein AUF1. Gene 149: 315–319.
   PubMedGoogle Scholar
• Fields, A. P., G. R. Pettit, and W. S. May. 1988. Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C. J. Biol. Chem. 263: 8253–8260.
   PubMed Web of Science ®Google Scholar
• Gillis, P., and J. S. Malter. 1991. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. J. Biol. Chem. 266: 3172–3177.
   PubMed Web of Science ®Google Scholar
• Greenberg, M. E., and J. G. Belasco. 1993. Control of the decay of labile protooncogene and cytokine mRNAs, p. 199–218. In J. G. Belasco and G. Brawerman (ed.), Control of messenger RNA stability. Academic Press, Inc., San Diego, Calif.
   Google Scholar
• Gurevich, V. V., I. D. Pokrovskaya, T. A. Obukhova, and S. A. Zozulya. 1991. Preparative in vitro mRNA synthesis using SP6 and T7 RNA polymerases. Anal. Biochem. 195: 207–213.
   PubMedGoogle Scholar
• Hamilton, B. J., E. Nagy, J. S. Malter, B. A. Arrick, and W. F. Rigby. 1993. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J. Biol. Chem. 268: 8881–8887.
   PubMed Web of Science ®Google Scholar
• Han, J., and B. Beutler. 1990. The essential role of the UA-rich sequence in endotoxin-induced cachectin/TNF synthesis. Eur. Cytokine Netw. 1: 71–75.
   PubMedGoogle Scholar
• Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171: 465–475. (Erratum, 171:971-972.)
   PubMed Web of Science ®Google Scholar
• Han, J., G. Huez, and B. Beutler. 1991. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J. Immunol. 146: 1843–1848.
   PubMed Web of Science ®Google Scholar
• Han, J. H., B. Beutler, and G. Huez. 1991. Complex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages. Biochim. Biophys. Acta 1090: 22–28.
   PubMedGoogle Scholar
• Jackson, R. J. 1993. Cytoplasmic regulation of mRNA function: the importance of the 3′-untranslated region. Cell 74: 9–14.
   PubMed Web of Science ®Google Scholar
• Jacob, C. O. 1992. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol. Today. 13: 122–125.
   Google Scholar
• Jacob, C. O., and N. B. Tashman. 1993. Disruption in the AU motif of the mouse TNF-alpha 3′ UTR correlates with reduced TNF production by macrophages in vitro. Nucleic Acids Res. 21: 2761–2766.
   PubMedGoogle Scholar
• Jochum, C., R. Voth, S. Rossol, K.-H. Meyer zum Buschenfelde, G. Hess, H. Will, H. C. Schroder, R. Steffen, and W. E. G. Müller. 1990. Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J. Virol. 64: 1956–1963.
   PubMedGoogle Scholar
• Katz, D. A., N. G. Theodorakis, D. W. Cleveland, T. Lindsten, and C. B. Thompson. 1994. AU-A, an RNA-binding activity distinct from hnRNP A1, is selective for AUUUA repeats and shuttles between the nucleus and thee cytoplasm. Nucleic Acids Res. 22: 238–246.
   PubMedGoogle Scholar
• Kovacs, E. J., D. Radzioch, H. A. Young, and L. Varesio. 1988. Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol. 141: 3101–3105.
   PubMed Web of Science ®Google Scholar
• Kruys, V., K. Kemmer, A. Shakhov, V. Jongeneel, and B. Beutler. 1992. Constitutive activity of the tumor necrosis factor promoter is cancelled by the 3′ untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect. Proc. Natl. Acad. Sci. USA 89: 673–677.
   PubMed Web of Science ®Google Scholar
• Kruys, V., O. Marinx, G. Shaw, J. Deschamps, and G. Huez. 1989. Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245: 852–854.
   PubMed Web of Science ®Google Scholar
• Lagnado, C. A., C. Y. Brown, and G. J. Goodall. 1994. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A) (U/A). Mol. Cell. Biol. 14: 7984–7995.
   PubMed Web of Science ®Google Scholar
• Malter, J. S. 1989. Identification of an AUUUA-specific messenger RNA binding protein. Science 246: 664–666.
   PubMed Web of Science ®Google Scholar
• Matic, M., and S. R. Simon. 1992. Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages. Infect. Immun. 60: 3756–3762.
   PubMedGoogle Scholar
• Müller, W. E. G., H. Slor, K. Pfeifer, P. Huhn, A. Bek, S. Orsulic, H. Ushijima, and H. C. Schroder. 1992. Association of AUUUA-binding protein with A+U-rich mRNA during nucleo-cytoplasmic transport. J. Mol. Biol. 226: 721–733.
   PubMedGoogle Scholar
• Old, L. J. 1985. Tumor necrosis factor (TNF). Science 230: 630–632.
   PubMed Web of Science ®Google Scholar
• Ozols, J. 1990. Preparation of membrane fractions. Methods Enzymol. 182: 225–235.
   PubMedGoogle Scholar
• Parida, S. K., and G. E. Grau. 1993. Role of TNF in immunopathology of leprosy. Res. Immunol. 144: 376–384.
   PubMedGoogle Scholar
• Radzioch, D., T. Hudson, M. Boule, L. Barrera, J. W. Urbance, L. Varesio, and E. Skamene. 1991. Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J. Leukocyte Biol. 50: 263–272.
   PubMedGoogle Scholar
• Schiavi, S. C., J. G. Belasco, and M. E. Greenberg. 1992. Regulation of proto-oncogene mRNA stability. Biochim. Biophys. Acta 1114: 95–106.
   PubMedGoogle Scholar
• Schroder, H. C., K. Dose, R. K. Zahn, and W. E. G. Müller. 1980. Isolation and characterization of the novel polyadenylate- and polyuridylate-degrading acid endoribonuclease V from calf thymus. J. Biol. Chem. 255: 5108–5112.
   PubMedGoogle Scholar
• Shaw, G., and R. Kamen. 1988. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659–667.
   Google Scholar
• Shyu, A. B., J. G. Belasco, and M. E. Greenberg. 1991. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5: 221–331.
   PubMed Web of Science ®Google Scholar
• Standiford, T. J., and R. M. Strieter. 1992. TNF and IL-1 in sepsis: good cytokines gone bad [editorial comment]. J. Lab. Clin. Med. 120: 179–180.
   PubMedGoogle Scholar
• Strieter, R. M., S. L. Kunkel, and R. C. Bone. 1993. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit. Care Med. 21: S447–S463.
   PubMed Web of Science ®Google Scholar
• Sung, S. J., J. A. Walters, and S. M. Fu. 1992. Stimulation of tumor necrosis factor alpha production in human monocytes by inhibitors of protein phosphatase 1 and 2A. J. Exp. Med. 176: 897–901.
   PubMedGoogle Scholar
• Ulich, T. R., S. S. Shin, and J. del Castillo. 1993. Haematologic effects of TNF. Res. Immunol. 144: 347–354.
   PubMedGoogle Scholar
• Vakalopoulou, E., J. Schaack, and T. Shenk. 1991. A 32-kilodalton protein binds to AU-rich domains in the 3′-untranslated regions of rapidly degraded mRNAs. Mol. Cell. Biol. 11: 3355–3364.
   PubMed Web of Science ®Google Scholar
• Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411–452.
   PubMed Web of Science ®Google Scholar
• You, Y., C. Y. Chen, and A. B. Shyu. 1992. U-rich sequence-binding proteins interacting with a 20-nucleotide U-rich sequence in the 3′ untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol. Cell. Biol. 12: 2931–2940.
   PubMedGoogle Scholar
• Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. DeMaria, D. Crater, K. DeHaven, L. Long, and G. Brewer. 1993. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13: 7652–7665.
   PubMed Web of Science ®Google Scholar
• Zubiaga, A. M., J. G. Belasco, and M. E. Greenberg. 1995. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15: 2219–2230.
   PubMed Web of Science ®Google Scholar
• Zuckerman, S. H., G. F. Evans, Y. M. Snyder, and W. D. Roeder. 1989. Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. J. Immunol. 143: 1223–1227.
   PubMed Web of Science ®Google Scholar